{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-220721","form_type":"8-K","ticker":"SABS","cik":"0001833214","company_name":"SAB Biotherapeutics, Inc.","filed_at":"2025-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.217736+00:00","generated_at":"2026-05-17T05:35:59.366601+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SAB Biotherapeutics shareholders approve 24.18M share increase and Series B conversion at less than minimum price","bullets":["Shareholders approved increasing plan shares by 24,180,000 to 31,932,466 total; evergreen cap raised to 73,750,000 shares.","Approved issuance of over 19.99% of outstanding common stock upon Series B Preferred conversion at less than Nasdaq minimum price, deemed a potential change of control.","Proposal 1 (conversion) passed with 5,502,026 votes for, 515,275 against, 35,744 abstentions.","Proposal 2 (plan amendment) passed with 5,089,862 votes for, 951,598 against, 11,585 abstentions.","Approximately 54.5% of outstanding shares were present, forming a quorum."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-220721","json":"https://secwatch.observer/filing/0001193125-25-220721.json","markdown":"https://secwatch.observer/filing/0001193125-25-220721.md","text":"https://secwatch.observer/filing/0001193125-25-220721.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525220721/0001193125-25-220721-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525220721/sabs-20250926.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:35:59.366601+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}